These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y; Sklar GN; Borkowski A; Kyprianou N Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [TBL] [Abstract][Full Text] [Related]
28. Expression of galactosyltransferase in prostatic tumors. Amselgruber WM; Sinowatz F; Kölle S; Lincoln DT; Kayser K Nutrition; 1995; 11(5 Suppl):638-42. PubMed ID: 8748240 [TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201 [TBL] [Abstract][Full Text] [Related]
30. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study. Sasor A; Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901 [TBL] [Abstract][Full Text] [Related]
31. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Nakajima M; Welch DR; Wynn DM; Tsuruo T; Nicolson GL Cancer Res; 1993 Dec; 53(23):5802-7. PubMed ID: 8242639 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Fixemer T; Remberger K; Bonkhoff H Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580 [TBL] [Abstract][Full Text] [Related]
33. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
34. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer. Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 2001; 15(1):65-70. PubMed ID: 11286132 [TBL] [Abstract][Full Text] [Related]
36. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Leav I; McNeal JE; Ho SM; Jiang Z Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556 [TBL] [Abstract][Full Text] [Related]
37. Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma. Reid WA; Branch T; Gorman C; Kay J J Pathol; 1990 Mar; 160(3):203-7. PubMed ID: 2110593 [TBL] [Abstract][Full Text] [Related]
38. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma. Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836 [TBL] [Abstract][Full Text] [Related]
40. Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Dehan P; Waltregny D; Beschin A; Noel A; Castronovo V; Tryggvason K; De Leval J; Foidart JM Am J Pathol; 1997 Oct; 151(4):1097-104. PubMed ID: 9327743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]